Sort
82,697 grants matching “vaccine development”
ADOLESCENT MEDICINE TRIALS UNIT
$854,519Donna Futterman · Albert Einstein College Of Medicine · U01 · FY2013 · HD
US-Nigerian Cancer Control Center for Research on Implementation Science and Equity (C3-RISE)
$854,493Juliet Iwelunmor · Washington University · U54 · FY2024 · CA
Heritable immunization of the white-footed mouse reservoir of Lyme disease
$854,479Kevin Esvelt · Massachusetts Institute Of Technology · R01 · FY2024 · AI
Non-Human Primate Core (NHP Core)
$854,320Koen K Van Rompay · Duke University · P01 · FY2017 · AI
Early life B cell responses and inflammation following SARS-CoV-2 infection
$854,272Genevieve Giny Fouda Amou Ou · Duke University · R01 · FY2021 · AI
Native American Research Centers For Health (NARCH XII)
$854,230Daniel J. Calac · Indian Health Council, Inc. · S06 · FY2022 · GM
Zika virus nonstructural protein 5 inhibition of interferon signaling
$854,154Matthew J Evans · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI
Global Analysis of Cellular Networks Involved In Restriction of HIV Replication
$854,115Sumit K Chanda · Salk Institute For Biological Studies · P01 · FY2011 · AI
Unmasking the roles of viral glycoproteins in oral transmission of KSHV
$854,017Javier Gordon Ogembo · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
IDENTIFYING NOVEL VIRUSES IN HUMAN MALIGNANCY
$853,952Nathan D Wolfe · Metabiota, Inc · RC2 · FY2010 · CA
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2
$853,827Steven B Abramson · New York University School Of Medicine · R01 · FY2023 · HL
Interaction of HIV envelope with cell surface receptors
$853,757Anthony S. Fauci · Niaid Extramural Activities · Z01 · FY2007 · AI
Center for the Study of Innate Immunity to HCV Infection
$853,750Michael J Gale · University Of Washington · U19 · FY2010 · AI
Neoantigen Vaccination for Lynch Syndrome Immunoprevention
$853,661Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · U01 · FY2018 · CA
PD-1 blockade as a therapy for SIV/AIDS
$853,656Rama Rao Amara · Emory University · R56 · FY2011 · AI
Molecular Basis of KSHV oncogenesis
$853,521Jae U Jung · Cleveland Clinic Lerner Com-Cwru · R35 · FY2022 · CA
Development of a Mucosal Nanoemulsion-Adjuvanted RSV Vaccine using Recombinant Pre-Fusion F Protein
$853,503Shyamala Ganesan · Bluewillow Biologics, Inc. · R44 · FY2022 · AI
CTL for supertype natural IgE cytotoxic peptide (nECP) to guard against allergic asthma
$853,476Swey-Shen Chen · Ige Therapeutics, Inc. · R44 · FY2016 · AI
Harnessing oral mucosa vaccination to drive protective HIV antibody responses
$853,346Donald L Sodora · Seattle Biomedical Research Institute · R01 · FY2016 · DE
Testing Bridges to Better Health and Wellness for People Living with Serious Mental Illness in Puerto Rico
$853,279Eliut Rivera-Segarra · Ponce School Of Medicine · U54 · FY2025 · MD
Human Skin Disease Resource-based Center
$853,226Rachael Ann Clark · Brigham And Women'S Hospital · P30 · FY2018 · AR
Human Skin Disease Resource-based Center
$853,226Rachael Ann Clark · Brigham And Women'S Hospital · P30 · FY2020 · AR
Mucosal immunity and rectal challenge
$853,120Joseph John Mattapallil · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2010 · DE
Interaction of HIV envelope with cell surface receptors
$853,062Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Core C - The University of Texas Medical Branch at Galveston
$852,988Thomas William Geisbert · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2020 · AI